Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Biotechnology
$38.01
+0.97%
Mkt Cap $3.29B
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$50.67
Range $47.00 – $55.00
Implied Upside
+33.3%
Consensus $50.67 vs current $38.01
NASDAQ·Healthcare·Biotechnology
$38.01
+0.97%
Mkt Cap $3.29B
No recent rating data.
Price Target (15 analysts)
$50.67
Range $47.00 – $55.00
+33.3%
Consensus $50.67 vs current $38.01